Single-cell transcriptome analysis identifies novel biomarkers involved in major liver cancer subtypes
Author:
Swain Asish Kumar1, Pandey Prashant1, Sera Riddhi1, Yadav Pankaj1
Affiliation:
1. Indian Institute of Technology Jodhpur
Abstract
Abstract
Background
Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the two aggressive subtypes of liver cancer (LC). Immense cellular heterogeneity and crosstalk between cancer and healthy cells make it challenging to treat these cancer subtypes. To address these challenges, the study aims to systematically characterize the tumour heterogeneity of LC subtypes using single-cell RNA sequencing (scRNA-seq) datasets.
Method
The study combined 51927 single cells from HCC, ICC, and healthy scRNA-seq datasets. After integrating the datasets, cell groups with similar gene expression patterns are clustered and cluster annotation has been performed based on gene markers. Cell-cell communication analysis (CCA) was implemented to understand the crosstalk between various cell types. Further, differential gene expression analysis and enrichment analysis were carried out to identify unique molecular drivers associated with HCC and ICC.
Results
Our analysis identified T-cells, hepatocytes, epithelial cells, and monocyte are the major cell types present in the tumour microenvironment. Among them, abundance of natural killer (NK) cells in HCC, epithelial cells and hepatocytes in ICC were detected. CCA revealed key interaction between T-cells to NK cells in HCC and smooth muscle cells to epithelial cells in the ICC. Additionally, SOX4 and DTHD1 are the top differentially expressed genes (DEGs) in HCC, while keratin and CCL4 are in ICC. Enrichment analysis of DEGs reveals major up-regulated genes in HCC affect protein folding mechanism and in ICC alter pathways involved in cell adhesion.
Conclusion
The findings suggest potential targets for the development of novel therapeutic strategies for the treatment of these two aggressive subtypes of LC.
Publisher
Research Square Platform LLC
Reference43 articles.
1. An, Q., Liu, T., Wang, M.-Y., Yang, Y.-J., Zhang, Z.-D., Liu, Z.-J., others, 2021. KRT7 promotes epithelial-mesenchymal transition in ovarian cancer via the TGF-β/Smad2/3 signaling pathway. Oncology reports 45, 481–492. 2. Aran, D., Looney, A.P., Liu, L., Wu, E., Fong, V., Hsu, A., others, 2019. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nature immunology 20, 163–172. 3. S100P: a novel therapeutic target for cancer;Arumugam T;Amino acids,2011 4. The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing;Chen L;Cancer biology & medicine,2020 5. Chen, S., Huang, C., Liao, G., Sun, H., Xie, Y., Liao, C., others, 2023. Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences. Gut gutjnl-2022-328428. https://doi.org/10.1136/gutjnl-2022-328428
|
|